Main, Caitlin, Haig, Madeleine and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2023) P36 Towards a collaborative value assessment framework for provider-facing digital health technologies used in chronic disease management: Findings and Implications. Value in Health, 26 (12). S9 - S9. ISSN 1098-3015
Full text not available from this repository.Abstract
Objectives Value frameworks play an essential role in evaluating health technologies, including wide-reaching digital health technologies (DHTs). However, assessing the value of provider-facing DHTs poses unique challenges due to their complexities, broad impacts and data-related risks. This study aims to develop a collaborative value assessment framework specifically for provider-facing DHTs used in chronic disease management and explore key stakeholder opinions on where value lies. Methods Mixed methods comprising both primary and secondary evidence were utilized in this study. 34 indicators were proposed from an initial scoping review within six value domains: health inequalities, data rights and governance, technical and security characteristics, clinical characteristics, economic characteristics and user preferences. Subsequently, a three-round web-Delphi was conducted with 79 participants consisting of patients, HCPs, decision-makers, industry and academics (including policy experts). Three rounds were completed to update the framework and understand different stakeholders views on the indicators’ importance in the context of technology assessment. Results The framework started at 45 indicators based on participant contributions in qualitative round one and delivered 16 stable indicators with consensus after rounds two and three. The highest-rated indicators included strong information governance standards, long-term cost-effectiveness, and data integrity. However, high rates of instability and dissensus were observed, particularly by clinicians and policy experts in the data rights and governance domain, emphasizing the complexity and novelty of assessing provider-facing DHTs. Stakeholders demonstrated a need for better understanding and discussions on the value, impact and infrastructure requirements of these technologies. Conclusions The collaborative value assessment framework provides valuable insights into the assessment of provider-facing DHTs, but further discussions and refinement are necessary to address the complexity and uncertainties associated with these technologies. Continued stakeholder involvement and knowledge exchange are crucial for advancing the understanding and evaluation of provider-facing DHTs within the healthcare ecosystem.
Item Type: | Article |
---|---|
Official URL: | https://www.valueinhealthjournal.com/ |
Divisions: | LSE Health Health Policy |
Subjects: | R Medicine > RA Public aspects of medicine |
Date Deposited: | 08 Jul 2024 16:21 |
Last Modified: | 01 Nov 2024 05:47 |
URI: | http://eprints.lse.ac.uk/id/eprint/124135 |
Actions (login required)
View Item |